Home/Shop/Ipamorelin/Tesamorelin 10mg
Research grade
Peptide Blend
Dual peptide blend: Ipamorelin (5mg) + Tesamorelin (5mg) — GHS-R agonist paired with GHRH analog Two distinct GH-axis receptor targets in a single co-lyophilized vial For in vitro dual-mechanism GH-axis research only
$76.99 In stock
Research-Grade CompoundsManufactured to research-grade standards for laboratory research use only.
Discreet ShippingEvery order ships in plain, protective packaging.
In-House FulfillmentOrders are inspected, packed, and shipped directly by the Heritage Labs team.
Same-day dispatch on orders before 12:00 PM ET, Mon–Fri. Discreet, plain packaging.
In-House Fulfillment Orders are inspected, packed, and shipped directly by the Heritage Labs team. View Certificates of Analysis →
SSL 256-bit Secure Checkout
For laboratory research use only. Not for human or veterinary consumption. SKU IPTESA55.
Overview
Product details.
Ipamorelin / Tesamorelin Blend 5mg/5mg
Two peptides, two receptor systems, one vial. Ipamorelin is a selective ghrelin receptor (GHS-R) agonist — a pentapeptide that triggers GH release without touching cortisol or prolactin. Tesamorelin is a 44-amino-acid GHRH analog with a lipophilic trans-3-hexenoic acid cap that shields it from aminopeptidase degradation. They work through entirely different receptor mechanisms within the somatotropic axis, which is precisely the point of co-formulating them.
Research-Grade Compounds
Manufactured to research-grade standards for laboratory research use only.
Discreet Shipping
Every order ships in plain, protective packaging.
In-House Fulfillment
Orders are inspected, packed, and shipped directly by the Heritage Labs team.
Component breakdown
Ipamorelin (5mg)
Selective GHS-R agonist pentapeptide. CAS 170851-70-4. MW 711.85 g/mol. Characterized by Raun et al. as the first GH secretagogue with selectivity comparable to GHRH itself.
Tesamorelin (5mg)
Full-length GHRH analog (all 44 amino acids) with N-terminal lipophilic stabilization. CAS 218949-48-5. MW 5135.83 g/mol. A structurally different approach to GHRH receptor agonism than the truncated, tetra-substituted CJC-1295.
Why this pairing
GHRH receptor activation and ghrelin receptor signaling converge on pituitary somatotrophs through complementary cascades. Preclinical literature has characterized how these two inputs interact — the GHRH pathway through cAMP/PKA, the GHS-R pathway through PLC/IP3/calcium. Studying both under identical experimental conditions in a single reconstitution eliminates variability from separate preparations.
Specifications
Content 5mg Ipamorelin + 5mg Tesamorelin per vial Format Co-lyophilized powder Testing , both components verified
Storage
Lyophilized: -20°C Reconstituted: 2-8°C, use within 30 days
For laboratory research use only. Not for human or veterinary use.
For laboratory research use only. Not for human or veterinary use. This product is not a drug or supplement and is not intended to diagnose, treat, cure, or prevent any disease.
FDA DISCLAIMER: All products are intended for research use only as defined by the FDA. Not for use in diagnostic procedures, human use, or veterinary use. Products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. All products sold by Heritage Labs are intended strictly for laboratory research, analytical, or in-vitro purposes only. Heritage Labs operates as a chemical supplier and is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act. Additionally, Heritage Labs is not classified as an outsourcing facility under Section 503B of the same Act. The statements on this website have not been evaluated by the U.S. Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease.